Giving tranexamic acid with the anticoagulant clopidogrel before coronary artery bypass surgery was linked with lower odds of bleeding as well as improved platelet function, according to a study in the journal JAMA Surgery. Preoperative clopidogrel by itself was associated with increased bleeding risk and greater need for transfusions. "This extra protection [provided by tranexamic acid] against impaired platelet function improved the bleeding and transfusion outcomes in patients with clopidogrel persistence to a comparable level as that in patients with clopidogrel cessation," according to the study.
Combination lowers bleeding risk for bypass patients
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|